InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by KANTOFF AARON, Director. Director active across 1 company, notably Centessa Pharmaceuticals plc. Cumulatively, 2 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €212k. Activity tracked since 18 November 2021. The latest transaction was disclosed on 18 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
10,000 shares@ US$11.9850.0017% mcap100.0% of flowOrdinary SharesSEC:0000899243-21-045321
Ideal exit: 15 Aug 2022 (T+270)
10,000 shares@ US$11.9850.0017% mcap50.0% of flowOrdinary SharesSEC:0000899243-21-045321:0
Ideal exit: 15 Aug 2022 (T+270)
2 of 2 declarations
About KANTOFF AARON
Aaron Kantoff is a Director at Centessa Pharmaceuticals plc. In this role, he participates in strategic decision-making and governance of the company, bringing his expertise in the pharmaceutical sector.
